Gabapentin Capsules Recalled for Cross Contamination
Sun Pharmaceutical Industries is recalling Gabapentin Capsules, USP 300 mg, due to cross contamination. The recall affects approximately 12,876 bottles distributed nationwide.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: FDA classified this as Class III, which by definition indicates it is unlikely to cause adverse health consequences. The source text states only "cross contamination" as the reason without specifying what contaminant or harm is involved, and no illnesses or injuries are reported.
Plain-English summary
Sun Pharmaceutical Industries Inc. is recalling Gabapentin Capsules, USP 300 mg (Rx Only) due to cross contamination. The recalled product is available in 500-count bottles (NDC 62756-138-05) and 1000-count bottles (NDC 62756-138-04), distributed nationwide in the United States.
The recall covers specific lot numbers: HAD1458A (expires 04/2025), HAD2718A (expires 07/2025), and HAD3432A (expires 08/2025). Approximately 12,876 bottles are affected. This is a voluntary recall initiated by the manufacturer.
Patients taking the recalled gabapentin should contact their healthcare provider or pharmacist for instructions. Consumers with affected product should not stop taking their medication without medical guidance, as abrupt discontinuation may cause adverse health effects. Return unused product to the pharmacy.
The recalled product
- Product
- GABAPENTIN (GABAPENTIN)
- Brand
- GABAPENTIN
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug — Oral Prescription
- Hazard
- cross-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot # a) HAD1458A
- Exp. date 04/2025
- HAD2718A
- Exp. date 07/2025
- b) HAD3432A
- exp. date 08/2025
UPCs (5)
- 0362756204010
- 0362756202016
- 0362756138025
- 0362756137028
- 0362756139022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · GABAPENTIN
- ModerateGabapentin Capsules 100 mg recalled for defective blister packaging
FDA (Drugs) · 2025-07-09
- ModerateGabapentin 600mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- LowGabapentin Capsules 400 mg Recalled for Cross Contamination
FDA (Drugs) · 2025-04-16
- HighGabapentin 600 mg Tablets Recalled Due to Metformin Contamination
FDA (Drugs) · 2024-08-14
- ModerateGabapentin tablets recalled due to product mixup with foreign tablet
FDA (Drugs) · 2023-05-17
Same category
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22